RhyGaze

Series-A
rhygaze.com Biotech & Healthcare Basel, Switzerland 11-50
Total Funding $97M
Latest Round $86M Series-A
Last Announced Jan 10, 2025
Investors 5 Backers
Decision Makers 4 Verified

About RhyGaze

Develops gene therapies to restore sight for people with vision loss.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Basel, Switzerland
Team Size 11-50
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website rhygaze.com
Domain Registered Date Apr 22, 2024

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $86,000,000 · Series-A

    startupintros.com

  2. Capital Raise

    Raised $11,000,000 · Seed

    startupintros.com

  3. Milestone

    Website domain registered

    rhygaze.com

Investors & Backers

5
ARCH Venture Partners
BioGeneration Ventures
F-Prime Capital
GV
Novartis Venture Fund

Funding History

2 Rounds
Series-A · Jan 10, 2025
Seed · Jul 1, 2024

Founders & Leadership

1

Tracy Dowling

Chief Business Officer and General Counsel

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts